Hepatitis Treatment Program
肝炎治疗方案
Duration
8-12 weeks for Hep C; ongoing for Hep B
Recovery
No downtime during treatment, SVR confirmed at 12 weeks post-treatment for Hep C
Savings
~80% vs US
Average savings compared to US prices
Specialized hepatitis B and C treatment programs leveraging China's extensive experience in viral hepatitis management. Direct-acting antiviral (DAA) therapy achieves 95%+ cure rates for hepatitis C, while nucleos(t)ide analogue therapy provides effective long-term viral suppression for hepatitis B. Chinese hepatology centers benefit from treating the world's largest hepatitis patient population with cutting-edge protocols.
Viral Assessment
HBV DNA or HCV RNA quantification, genotyping, liver fibrosis staging with FibroScan, and resistance testing
Duration: 2-3 daysTreatment Initiation
Prescription of genotype-specific DAA regimen for HCV or nucleos(t)ide analogue for HBV, with baseline safety labs
Duration: 1 dayOn-treatment Monitoring
Regular viral load testing at weeks 4 and 8, liver function monitoring, and drug interaction management
Duration: 8-12 weeksSustained Response Confirmation
SVR12 testing for HCV cure confirmation, or viral suppression verification for HBV with long-term management plan
Duration: 12 weeks post-treatment- Access to generic DAAs at a fraction of Western brand-name drug costs
- World-leading expertise in hepatitis B from treating 90+ million carriers
- Comprehensive liver monitoring and cancer surveillance included
- High cure rates (>95%) for hepatitis C with modern DAA therapy
- Drug interactions with existing medications
- Rare reactivation of hepatitis B during HCV treatment
- Liver function changes requiring treatment modification
- Need for long-term compliance in hepatitis B management
Prices shown are approximate ranges for reference only. Actual costs vary by hospital, complexity, and individual patient needs. Always consult with healthcare professionals for medical decisions.